Model
Edge
Alnylam Pharmaceuticals, Inc.
0001511797
Filing type
4
Filing date
Oct 5, 2026
Updated
Oct 6, 2026 ยท 2:12 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership